非静脉曲张性消化道出血经导管栓塞治疗的患者特征与临床结局:单中心经验
该单中心回顾性分析纳入74例内镜治疗失败后行经导管栓塞(TAE)的非静脉曲张性上消化道出血患者,技术成功率98.7%,临床成功率85.1%,30天再出血率14.8%、死亡率13.5%。凝血功能障碍、输血量多、入院低血压与不良结局相关,栓塞胃左动脉者再出血率和死亡率更高。
要点
- TAE治疗非静脉曲张性上消化道出血技术成功率高,无造影相关并发症。
- 无造影剂外溢时经验性TAE与靶向TAE临床疗效相当。
- 凝血功能障碍、输血量多、入院低血压提示再出血和死亡风险高。
关键影像表现/征象
- TAE技术成功率为98.7%,1例失败因严重腹腔干狭窄。
- 临床成功率为85.1%,多数TAE因无造影剂外溢而经验性实施。
诊断标准与关键数值
- 30天再出血率为14.8%,死亡率为13.5%。
- 凝血功能障碍者再出血率45.5% vs. 17.5%(p=0.040),死亡率30% vs. 7.4%(p=0.012)。
- 死亡者输血悬浮红细胞单位数更多(13.6 ± 8.4 vs. 6.1 ± 5.4,p=0.020)。
- 入院低血压者死亡率27.8% vs. 8.9%(p=0.043)。
- 栓塞胃左动脉者再出血率37.5% vs. 8.6%(p=0.004),死亡率37.5% vs. 6.9%(p=0.002)。
临床应用与阅片要点
- 内镜治疗失败的非静脉曲张性上消化道出血可考虑TAE,无造影剂外溢时经验性栓塞仍有效。
- 术前评估凝血功能、输血需求和血压有助于风险分层。
- 栓塞胃左动脉时需警惕较高的再出血和死亡风险。
局限性
- 单中心回顾性设计,样本量有限,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Management of massive non-variceal upper gastrointestinal bleeding (NV-UGIB) can be challenging. Transarterial Embolization (TAE) is often the first therapeutic approach when endoscopic therapy fails before surgery. The purpose of this study is to analyze the technical success, and outcome for our patients with an NV-UGIB referred for TAE.
METHOD: This retrospective analysis included 74 consecutive patients with an NV-UGIB in whom TAE was performed after endoscopic treatment between February 2016 to May 2019 at Prisma Health-Upstate Greenville Memorial Hospital.
RESULTS: TAE was 98.7% technically successful, with a failure due to severe celiac stenosis, and 85.1% clinically successful. Most TAEs were performed empirically due to lack of extravasation yet were clinically as effective as targeted TAE. We noted a 30-day rebleeding rate and mortality rate of 14.8% and 13.5%, respectively. No complications were reported during the angiographic procedure. Subjects with coagulopathy had more rebleeding (45.5% vs. 17.5%, p = 0.040), and mortality (30% vs 7.4%, p = 0.012). Mortality was also associated with the number of transfused packed blood cells (13.6 ± 8.4 vs. 6.1 ± 5.4, p = 0.020) units and hypotension on admission (27.8% vs. 8.9%, p = 0.043). Interestingly, subjects that underwent left gastric artery (LGA) compared to non-LGA embolization had a higher rebleeding rate of (37.5% vs. 8.6%, p = 0.004) and a greater mortality rate of (37.5% vs. 6.9%, p = 0.002).
CONCLUSION: TAE is clinically effective in the presence or absence of contrast extravasation to treat uncontrolled or high-risk NV-UGIB. Less effective clinical outcomes regarding TAE targeting the LGA warrant further investigation.
引用
- Ephraim Joseph, Devane, Abrams, et al. Patient and endoscopic characteristics and clinical outcomes in subjects with non-variceal GI bleeding referred for transarterial embolization: a single-center experience. Abdom Radiol (NY). 2022. PMID: 36031627. doi:10.1007/s00261-022-03650-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。